Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia

Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomograph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Technology in cancer research & treatment 2009-02, Vol.8 (1), p.29-37
Hauptverfasser: Shueng, Pei-Wei, Lin, Shih-Chiang, Chong, Ngot-Swan, Lee, Hsing-Yi, Tien, Hui-Ju, Wu, Le-Jung, Chen, Chien-An, Lee, Jason J. S., Hsieh, Chen-Hsi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 37
container_issue 1
container_start_page 29
container_title Technology in cancer research & treatment
container_volume 8
creator Shueng, Pei-Wei
Lin, Shih-Chiang
Chong, Ngot-Swan
Lee, Hsing-Yi
Tien, Hui-Ju
Wu, Le-Jung
Chen, Chien-An
Lee, Jason J. S.
Hsieh, Chen-Hsi
description Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV. A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively. The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.
doi_str_mv 10.1177/153303460900800105
format Article
fullrecord <record><control><sourceid>sage_AFRWT</sourceid><recordid>TN_cdi_crossref_primary_10_1177_153303460900800105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_153303460900800105</sage_id><sourcerecordid>10.1177_153303460900800105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</originalsourceid><addsrcrecordid>eNp9kE1PAjEQhhujEUT_gAfTi0dkut1Pb0hASCBe1vNmttuVkt3tpl2CnPzrloB4MHEunbTPM828hNwzeGIsikYs4By4H0ICEAMwCC5I_3A5BM7jy3Pvhz1yY-0GwAtDzq5JjyUsDD0f-uQr1R1WdIXG6B1dGIOFwk7phu5Ut6ZzWSnh3lNd624tDbZ7WmpDX3Qjf6TUYGPbCpvuKOqSrrZVp9rKIXtZ6Rqf6UwZ29HpZyuNko2QVDV0bBXekqsSKyvvTueAvM-m6WQ-XL69Libj5VD4LOiGUeCJOAYRljnySBaCM8aToChziHOPMz8vkoC5lTBIpM_zKMLcj1kAIskRypgPiHecK4y21sgya42q0ewzBtkhzexvmk56OErtNq9l8auc4nPA4wlA62IqXRJC2TPnMYhdJY4bHTmLHzLb6K1p3LL_ff0NrQWK8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</title><source>Sage Journals GOLD Open Access 2024</source><creator>Shueng, Pei-Wei ; Lin, Shih-Chiang ; Chong, Ngot-Swan ; Lee, Hsing-Yi ; Tien, Hui-Ju ; Wu, Le-Jung ; Chen, Chien-An ; Lee, Jason J. S. ; Hsieh, Chen-Hsi</creator><creatorcontrib>Shueng, Pei-Wei ; Lin, Shih-Chiang ; Chong, Ngot-Swan ; Lee, Hsing-Yi ; Tien, Hui-Ju ; Wu, Le-Jung ; Chen, Chien-An ; Lee, Jason J. S. ; Hsieh, Chen-Hsi</creatorcontrib><description>Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV. A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively. The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.</description><identifier>ISSN: 1533-0346</identifier><identifier>EISSN: 1533-0338</identifier><identifier>DOI: 10.1177/153303460900800105</identifier><identifier>PMID: 19166240</identifier><identifier>CODEN: TCRTBS</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Biological and medical sciences ; Bone Marrow - radiation effects ; Female ; Hematologic and hematopoietic diseases ; Hematopoietic Stem Cell Transplantation ; Humans ; Immunodeficiencies. Immunoglobulinopathies ; Immunoglobulinopathies ; Immunopathology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; Multiple Myeloma - therapy ; Radiotherapy Planning, Computer-Assisted ; Tomography, Spiral Computed - methods ; Transplantation Conditioning ; Whole-Body Irradiation</subject><ispartof>Technology in cancer research &amp; treatment, 2009-02, Vol.8 (1), p.29-37</ispartof><rights>2009 SAGE Publications</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</citedby><cites>FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/153303460900800105$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/153303460900800105$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21947,27832,27903,27904,44924,45312</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/153303460900800105?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21088889$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19166240$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shueng, Pei-Wei</creatorcontrib><creatorcontrib>Lin, Shih-Chiang</creatorcontrib><creatorcontrib>Chong, Ngot-Swan</creatorcontrib><creatorcontrib>Lee, Hsing-Yi</creatorcontrib><creatorcontrib>Tien, Hui-Ju</creatorcontrib><creatorcontrib>Wu, Le-Jung</creatorcontrib><creatorcontrib>Chen, Chien-An</creatorcontrib><creatorcontrib>Lee, Jason J. S.</creatorcontrib><creatorcontrib>Hsieh, Chen-Hsi</creatorcontrib><title>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</title><title>Technology in cancer research &amp; treatment</title><addtitle>Technol Cancer Res Treat</addtitle><description>Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV. A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively. The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.</description><subject>Biological and medical sciences</subject><subject>Bone Marrow - radiation effects</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - therapy</subject><subject>Radiotherapy Planning, Computer-Assisted</subject><subject>Tomography, Spiral Computed - methods</subject><subject>Transplantation Conditioning</subject><subject>Whole-Body Irradiation</subject><issn>1533-0346</issn><issn>1533-0338</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PAjEQhhujEUT_gAfTi0dkut1Pb0hASCBe1vNmttuVkt3tpl2CnPzrloB4MHEunbTPM828hNwzeGIsikYs4By4H0ICEAMwCC5I_3A5BM7jy3Pvhz1yY-0GwAtDzq5JjyUsDD0f-uQr1R1WdIXG6B1dGIOFwk7phu5Ut6ZzWSnh3lNd624tDbZ7WmpDX3Qjf6TUYGPbCpvuKOqSrrZVp9rKIXtZ6Rqf6UwZ29HpZyuNko2QVDV0bBXekqsSKyvvTueAvM-m6WQ-XL69Libj5VD4LOiGUeCJOAYRljnySBaCM8aToChziHOPMz8vkoC5lTBIpM_zKMLcj1kAIskRypgPiHecK4y21sgya42q0ewzBtkhzexvmk56OErtNq9l8auc4nPA4wlA62IqXRJC2TPnMYhdJY4bHTmLHzLb6K1p3LL_ff0NrQWK8A</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Shueng, Pei-Wei</creator><creator>Lin, Shih-Chiang</creator><creator>Chong, Ngot-Swan</creator><creator>Lee, Hsing-Yi</creator><creator>Tien, Hui-Ju</creator><creator>Wu, Le-Jung</creator><creator>Chen, Chien-An</creator><creator>Lee, Jason J. S.</creator><creator>Hsieh, Chen-Hsi</creator><general>SAGE Publications</general><general>Adenine Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20090201</creationdate><title>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</title><author>Shueng, Pei-Wei ; Lin, Shih-Chiang ; Chong, Ngot-Swan ; Lee, Hsing-Yi ; Tien, Hui-Ju ; Wu, Le-Jung ; Chen, Chien-An ; Lee, Jason J. S. ; Hsieh, Chen-Hsi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Bone Marrow - radiation effects</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - therapy</topic><topic>Radiotherapy Planning, Computer-Assisted</topic><topic>Tomography, Spiral Computed - methods</topic><topic>Transplantation Conditioning</topic><topic>Whole-Body Irradiation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shueng, Pei-Wei</creatorcontrib><creatorcontrib>Lin, Shih-Chiang</creatorcontrib><creatorcontrib>Chong, Ngot-Swan</creatorcontrib><creatorcontrib>Lee, Hsing-Yi</creatorcontrib><creatorcontrib>Tien, Hui-Ju</creatorcontrib><creatorcontrib>Wu, Le-Jung</creatorcontrib><creatorcontrib>Chen, Chien-An</creatorcontrib><creatorcontrib>Lee, Jason J. S.</creatorcontrib><creatorcontrib>Hsieh, Chen-Hsi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Technology in cancer research &amp; treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Shueng, Pei-Wei</au><au>Lin, Shih-Chiang</au><au>Chong, Ngot-Swan</au><au>Lee, Hsing-Yi</au><au>Tien, Hui-Ju</au><au>Wu, Le-Jung</au><au>Chen, Chien-An</au><au>Lee, Jason J. S.</au><au>Hsieh, Chen-Hsi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</atitle><jtitle>Technology in cancer research &amp; treatment</jtitle><addtitle>Technol Cancer Res Treat</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>8</volume><issue>1</issue><spage>29</spage><epage>37</epage><pages>29-37</pages><issn>1533-0346</issn><eissn>1533-0338</eissn><coden>TCRTBS</coden><abstract>Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV. A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively. The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>19166240</pmid><doi>10.1177/153303460900800105</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1533-0346
ispartof Technology in cancer research & treatment, 2009-02, Vol.8 (1), p.29-37
issn 1533-0346
1533-0338
language eng
recordid cdi_crossref_primary_10_1177_153303460900800105
source Sage Journals GOLD Open Access 2024
subjects Biological and medical sciences
Bone Marrow - radiation effects
Female
Hematologic and hematopoietic diseases
Hematopoietic Stem Cell Transplantation
Humans
Immunodeficiencies. Immunoglobulinopathies
Immunoglobulinopathies
Immunopathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical sciences
Middle Aged
Multiple Myeloma - therapy
Radiotherapy Planning, Computer-Assisted
Tomography, Spiral Computed - methods
Transplantation Conditioning
Whole-Body Irradiation
title Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A55%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Total%20Marrow%20Irradiation%20with%20Helical%20Tomotherapy%20for%20Bone%20Marrow%20Transplantation%20of%20Multiple%20Myeloma:%20First%20Experience%20in%20Asia&rft.jtitle=Technology%20in%20cancer%20research%20&%20treatment&rft.au=Shueng,%20Pei-Wei&rft.date=2009-02-01&rft.volume=8&rft.issue=1&rft.spage=29&rft.epage=37&rft.pages=29-37&rft.issn=1533-0346&rft.eissn=1533-0338&rft.coden=TCRTBS&rft_id=info:doi/10.1177/153303460900800105&rft_dat=%3Csage_AFRWT%3E10.1177_153303460900800105%3C/sage_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19166240&rft_sage_id=10.1177_153303460900800105&rfr_iscdi=true